MD

MD Medical Group Investments PLCMOEX MDMG Stock Report

Last reporting period 30 Jun, 2024

Updated 06 Nov, 2024

Last price

Market cap $B

0.647

Micro

Exchange

MISX - Moscow Exchange

MDMG.ME Stock Analysis

MD

Attractive

Based on Eyestock quantitative analysis, MDMG.ME`s fundamental data and valuation indicate an investment grade of Attractive at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

115/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

3.8 %

Undervalued

Market cap $B

0.647

Dividend yield

Shares outstanding

75.13 B

MD Medical Group Investments Plc operates as an investment holding company, which engages in the provision of medical services. The firm is a provider of private healthcare for women and children. The firm's services include obstetrics and gynecology, pediatrics, fertility and in vitro fertilization (IVF) treatment, and other services, including laboratory services, stem cell storage, trauma, rehabilitation, dental care and surgery, among other services. The firm operates 23 medical centers across Russia, which includes four hospitals and 19 out-patient clinics in Moscow, Ryazan, Yaroslavl, St. Petersburg, Samara and Samara Region, Perm, Ufa, Novosibirsk and Irkutsk. The company offers both in-patient care hospitals and out-patient care clinics. The firm owns its own laboratory, stem cell bank and ambulance service.

View Section: Eyestock Rating